USING BOTULINUM TOXIN FOR THE TREATMENT OF GASTROPARESIS (GP) FOR THE SELECTION OF PATIENTS WITH HIGHER CLINICAL SUCCESS, IMPROVED QUALITY OF LIFE (QOL), AND IMPROVED SOCIAL FUNCTIONING POST GASTRIC PERORAL ENDOSCOPIC MYOTOMY (GPOEM)

Date
2023-07-28
Language
American English
Embargo Lift Date
Department
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
Can't use the file because of accessibility barriers? Contact us with the title of the item, permanent link, and specifics of your accommodation need.
Abstract

BACKGROUND While G-POEM remains an effective and exciting treatment for GP patients, predictors of clinical success remain poorly characterized. Botox injection of the pylorus prior to committing to G POEM can help differentiate those who might have a favorable clinical response to this procedure in patients with GP.

METHODS To evaluate the utility of Botox injection prior to G-POEM, 124 patients with clinically diagnosed GP who underwent a GPOEM were assessed in this retrospective cohort study. All G-POEM procedures were conducted at a single center and were completed between February 2018 and May 2023. Patients who had received intrapyloric Botox injection (n=79) had QoL and clinical success rates compared to patients who received other treatment options (n=45). Results were assessed at 1-, 3-, 6-, 12-, 24-, 36-, 48-months post G-POEM.

RESULTS When assessing symptom severity, the difference between the change in GCSI values for Botox patients and patients receiving other prior therapy was statistically significant at 6 months post GPOEM; +1.27 for Botox patients vs +0.55 for other treatments (p-value of 0.03). At this 6-month checkpoint, 64% of the Botox group achieved clinical success compared to 37.5% for the other treatment group. When comparing QoL, intrapyloric Botox injection has statistically significant improvements in SF-36 total score at 1, 3-, 6-, 12-, and 36-months post G-POEM, while patients receiving other treatments had no statistically significant improvements in their SF-36 total scores.

CONCLUSION We hypothesize that clinical improvement on pre GPOEM Botox selects patients with a higher component of pyloric spasm who end up responding more favorably to GPOEM.

IMPLICATIONS Intrapyloric Botox injection is technically feasible in almost all patients with GP and does not require special expertise, training, or equipment; therefore, this should be strongly considered prior to referring a patient for G-POEM.

Description
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Kais A, Al-Haddad M. Using Botulinum Toxin for the Treatment of Gastroparesis (GP) Post Gastric Peroral Endoscopic Myotomy (GPOEM) Knowledge and Intent to Use among IUPUI Students. Poster presented at: Indiana University Medical Student Program for Research and Scholarship (IMPRS) Research Symposium; July 27-28, 2023; Indianapolis, IN.
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Source
Alternative Title
Type
Poster
Presentation
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Version
Full Text Available at
This item is under embargo {{howLong}}
Collections